Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Strong antimicrobial activity of xanthohumol and other derivatives from hops (Humulus lupulus L.) on gut anaerobic bacteria

P. Cermak, J. Olsovska, A. Mikyska, M. Dusek, Z. Kadleckova, J. Vanicek, O. Nyc, K. Sigler, V. Bostikova, P. Bostik,

. 2017 ; 125 (11) : 1033-1038. [pub] 20170928

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016315

Anaerobic bacteria, such as Bacteroides fragilis or Clostridium perfringens, are part of indigenous human flora. However, Clostridium difficile represents also an important causative agent of nosocomial infectious antibiotic-associated diarrhoea. Treatment of C. difficile infection is problematic, making it imperative to search for new compounds with antimicrobial properties. Hops (Humulus lupulus L.) contain substances with antibacterial properties. We tested antimicrobial activity of purified hop constituents humulone, lupulone and xanthohumol against anaerobic bacteria. The antimicrobial activity was established against B. fragilis, C. perfringens and C. difficile strains according to standard testing protocols (CLSI, EUCAST), and the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBC) were calculated. All C. difficile strains were toxigenic and clinically relevant, as they were isolated from patients with diarrhoea. Strongest antimicrobial effects were observed with xanthohumol showing MIC and MBC values of 15-107 μg/mL, which are close to those of conventional antibiotics in the strains of bacteria with increased resistance. Slightly higher MIC and MBC values were obtained with lupulone followed by higher values of humulone. Our study, thus, shows a potential of purified hop compounds, especially xanthohumol, as alternatives for treatment of infections caused by select anaerobic bacteria, namely nosocomial diarrhoea caused by resistant strains.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016315
003      
CZ-PrNML
005      
20181211084224.0
007      
ta
008      
180515s2017 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/apm.12747 $2 doi
035    __
$a (PubMed)28960474
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Cermak, Pavel $u Thomayer Hospital, Videnska 800, Prague, Czech Republic.
245    10
$a Strong antimicrobial activity of xanthohumol and other derivatives from hops (Humulus lupulus L.) on gut anaerobic bacteria / $c P. Cermak, J. Olsovska, A. Mikyska, M. Dusek, Z. Kadleckova, J. Vanicek, O. Nyc, K. Sigler, V. Bostikova, P. Bostik,
520    9_
$a Anaerobic bacteria, such as Bacteroides fragilis or Clostridium perfringens, are part of indigenous human flora. However, Clostridium difficile represents also an important causative agent of nosocomial infectious antibiotic-associated diarrhoea. Treatment of C. difficile infection is problematic, making it imperative to search for new compounds with antimicrobial properties. Hops (Humulus lupulus L.) contain substances with antibacterial properties. We tested antimicrobial activity of purified hop constituents humulone, lupulone and xanthohumol against anaerobic bacteria. The antimicrobial activity was established against B. fragilis, C. perfringens and C. difficile strains according to standard testing protocols (CLSI, EUCAST), and the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBC) were calculated. All C. difficile strains were toxigenic and clinically relevant, as they were isolated from patients with diarrhoea. Strongest antimicrobial effects were observed with xanthohumol showing MIC and MBC values of 15-107 μg/mL, which are close to those of conventional antibiotics in the strains of bacteria with increased resistance. Slightly higher MIC and MBC values were obtained with lupulone followed by higher values of humulone. Our study, thus, shows a potential of purified hop compounds, especially xanthohumol, as alternatives for treatment of infections caused by select anaerobic bacteria, namely nosocomial diarrhoea caused by resistant strains.
650    _2
$a anaerobióza $x fyziologie $7 D000693
650    _2
$a antibakteriální látky $x izolace a purifikace $x farmakologie $7 D000900
650    _2
$a Bacteroides fragilis $x účinky léků $x růst a vývoj $7 D001441
650    _2
$a Clostridioides difficile $x účinky léků $x růst a vývoj $x patogenita $7 D016360
650    _2
$a Clostridium perfringens $x účinky léků $x růst a vývoj $7 D003016
650    _2
$a infekce spojené se zdravotní péčí $x mikrobiologie $7 D003428
650    _2
$a cyklohexeny $x izolace a purifikace $x farmakologie $7 D053138
650    _2
$a průjem $x mikrobiologie $7 D003967
650    _2
$a pseudomembranózní enterokolitida $x mikrobiologie $7 D004761
650    _2
$a flavonoidy $x izolace a purifikace $x farmakologie $7 D005419
650    _2
$a lidé $7 D006801
650    _2
$a Humulus $x chemie $7 D027582
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a rostlinné extrakty $x chemie $7 D010936
650    _2
$a propiofenony $x izolace a purifikace $x farmakologie $7 D011427
650    _2
$a symbióza $x fyziologie $7 D013559
650    _2
$a terpeny $x izolace a purifikace $x farmakologie $7 D013729
655    _2
$a časopisecké články $7 D016428
700    1_
$a Olsovska, Jana $u Research Institute of Brewing and Malting, PLC, Prague, Czech Republic.
700    1_
$a Mikyska, Alexandr $u Research Institute of Brewing and Malting, PLC, Prague, Czech Republic.
700    1_
$a Dusek, Martin $u Research Institute of Brewing and Malting, PLC, Prague, Czech Republic.
700    1_
$a Kadleckova, Zuzana $u Thomayer Hospital, Videnska 800, Prague, Czech Republic.
700    1_
$a Vanicek, Jiri $u Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.
700    1_
$a Nyč, Otakar $u Department of Medical Microbiology 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague 5, Czech Republic. $7 uk2007399535
700    1_
$a Sigler, Karel $u Institute of Microbiology, Czech Academy of Sciences, Prague 4, Czech Republic.
700    1_
$a Bostikova, Vanda $u Faculty of Military Medical Sciences, University of Defence, Hradec Kralove, Czech Republic.
700    1_
$a Bostik, Pavel $u Faculty of Military Medical Sciences, University of Defence, Hradec Kralove, Czech Republic.
773    0_
$w MED00009218 $t APMIS acta pathologica, microbiologica, et immunologica Scandinavica $x 1600-0463 $g Roč. 125, č. 11 (2017), s. 1033-1038
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28960474 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20181211084349 $b ABA008
999    __
$a ok $b bmc $g 1299939 $s 1013155
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 125 $c 11 $d 1033-1038 $e 20170928 $i 1600-0463 $m APMIS. Acta pathologica, microbiologica et immunologica Scandinavica $n APMIS $x MED00009218
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace